iBIO is offering an exclusive virtual sneak peek into Fulton Labs and West End on Fulton – the first new wet and dry lab buildings built in downtown Chicago in decades, designed by one of the foremost development teams in the U.S. As you know better than anyone, Chicago’s primary opportunity for continued ecosystem growth has been new lab infrastructure, and it’s finally here.

Please join us for an interactive visualization of the new Fulton Market facilities, plus a conversation with John Flavin. John’s new biomedical startup platform, Portal Innovations, will anchor both buildings. Hear the latest developments on Portal’s work to accelerate innovation, from discovery through commercial proof of concept, for life sciences, medtech and bioinformatics companies.

Teri Willey returned to Indiana in 2018 to join Indiana University as an Executive Director of IU Ventures and to launch and manage the new Indiana Philanthropic Venture Fund (IU PhV). She is a member of The Dimension Mill/Velocities Investment Committee, a Director of the Venture Club of Indiana, an Advisor to OnCode Institute in the Netherlands, an Advisor to the Frankel Innovation Initiative and serves on the Board of several early stage companies.

Teri served as Vice President of Cold Spring Harbor Laboratory leading a new program for industry engagement, new ventures and intellectual property licensing; Vice President for Technology and Business Development for Mount Sinai School of Medicine; founding Chief Executive of Cambridge Enterprise, Ltd the technology commercialization affiliate of the University of Cambridge in England, which included the launch of the Discovery Fund; founder and Managing Partner of ARCH Development Partners, a seed and early stage venture fund focused on university and corporate spin-outs; Business Development for Endocyte, Inc., University of Notre Dame Business School Adjunct Faculty; and Vice President of Start-ups at ARCH Development Corporation, a subsidiary of the University of Chicago, which commercialized technology from the University and Argonne National Laboratory. Her prior experience also includes non-executive board positions with several early stage companies, technology transfer leadership roles at Northwestern University and Purdue Research Foundation, including the partnership to launch Cook Biotech, founding membership on the Indiana 21st Century Fund Board and business development for International Minerals and Chemical.

Teri has been an advisor to policy makers, universities, and companies, is a past President of the Association of University Technology Managers (AUTM), a former Bye Fellow of Christ’s College Cambridge in England and a Sagamore of the Wabash.

In a year marked by unexpected challenges and rapid change, staying connected with industry peers and keeping a watchful eye on market trends, policy developments and collaborations in the life sciences space is crucial to bringing innovations to market.

Join us virtually for our signature Life Sciences Dealmaking Symposium, where seasoned dealmakers, industry executives and technical experts come together with McDermott’s leading life sciences lawyers. Beginning October 20, we’ll bring you a series of three pre-Symposium programs focused on today’s most pressing concerns for life sciences dealmakers, all culminating in a half-day virtual program with multiple networking sessions, industry-leading keynote speakers and insights from investors, life sciences executives, policy experts and investment bankers.

iBIO Members save on registration with the code: LSDSMEM20

PROGRAM DETAILS

Virtual Life Sciences Dealmaking Symposium
Tuesday, November 17, 2020
8:00 am – 2:00 pm EST
*Networking platform will be open from 8:00 am – 6:00 pm EST*

AGENDA:

8:00 – 9:45 am.         Pre-event Networking

9:30 – 9:35 am.        Welcome Remarks
Krist Werling, Co-Chair, Life Sciences Industry Group, McDermott Will & Emery

9:35 – 10:00 am.      Michelle McMurry-Heath Keynote
President and CEO, Biotechnology Innovation Organization

10:00 – 10:40 am.    M&A Outlook: Expect the Unexpected
Moderator: Byron Kalogerou, Partner, McDermott Will & Emery
Kristie Bradford, Director, Intellectual Property, IBM Corporation
Dennis Crowley, Senior Vice President, Business Development & Licensing, Baxter
Patrice McNicoll, Co-head of Investment Banking, B. Riley Financial

10:40 – 11:10 am.    Sight Unseen: Cross-border Collaboration Goes Virtual
Moderator: Emmanuelle Trombe, Partner, McDermott Will & Emery
Frederic Scaerou, Lead Director, Business Development and Licensing, Servier Pharmaceuticals
Vivek Ramaswamy, CEO, Roivant Sciences
Rich Smith, Partner, McDermott Will & Emery

11:10 – 11:15 am     Bio Break

11:15 – 11:45 am.    Speed vs. Safety: Innovating with Urgency in Diagnostics & Vaccines
Moderator: Brian Malkin, Partner, McDermott Will & Emery
Steve Bossone, Senior Vice President, Chief Patent Counsel, Alnylam
Alan Wright, Chief Medical Officer, Roche Diagnostics
Sarah Columbia, Partner, McDermott Will & Emery
Michael Ryan, Partner, McDermott Will & Emery

11:45 am – 12:15 pm.    Digital Health Takes Center Stage: Will It Be The Hottest Sector for Dealmaking?
Moderator: Stephen Bernstein, Co-Chair, Life Sciences Industry Group, McDermott Will & Emery
Kathy Bergsteinsson, Managing Director, Morgan Stanley
Debbie Lin, Executive Director, Boehringer Ingelheim Venture Fund
Rene Quashie, Vice President, Policy and Regulatory Affairs, Digital Health, Consumer Technology Association
Jennifer Geetter, Partner, McDermott Will & Emery

12:15 – 12:45 pm.    Racial Justice in the Start-up Sector: the McDermott RISE Program
Moderator: Vernessa Pollard, Chair, FDA Practice, McDermott Will & Emery
Nathan Pelzer, CEO, Clinify Health
Kwame Ulmer, Founder, MedTech Color
Marshall Jackson, Partner, McDermott Will & Emery

12:45 – 1:30p.    Scott Gottlieb Keynote
Immediate Past Commissioner Food and Drug Administration (2017-2019); Former Senior Advisor – CMS

1:30 – 2:00 pm.    Post-event Networking

HealthTECH Startup Competition

Program Overview

In response to highly successful events over the past seven years, Insight Innovation Center and Matter are co-hosting the eighth annual HealthTECH Startup Competition on the week of November 16, 2020. This year’s event will be virtual, with the top ten leading early-stage device and digital health startup finalists competing for $20,000 in cash and prizes.

First-round startup competitors will be selected by a judging panel of leaders from academia, global corporations, investors, and community health organizations. They will narrow the list of eligible competitors down to the top 20 teams. The second round of vetting and review will identify the finalists that will present live in November at the HealthTECH Competition. Startups will provide a five-minute pitch followed by a five-minute Q&A during a private stream with the judges. On the merit of their live pitches, jurors will select the top three startups for cash and prize awards at the event.

On November 20th, all ten startups will give their final one-minute presentations to the larger audience of event attendees and judges. This is an opportunity to gain the attention of the attendees and take home the people’s choice award, voted by tweeting with the hashtag #InsightHealthTECH20. We hope you can attend this great event and look forward to hearing your voice in the People’s Choice.

The Illinois Department of Commerce and Economic Opportunity (DCEO) announced a $9 million Notice of Funding Opportunity to boost the development of wet labs across Illinois.

According to DCEO, grant funds will be awarded on a competitive basis to fund the construction or renovation of facilities that house wet lab space and promote the growth of life sciences in Illinois. The grant funds are limited to capital expenses. 

Preferred project locations will be where new wet lab development is likely to act as a catalyst to the local economy due to its proximity to other life sciences companies, researchers, and educational institutions.